CardioExchange Archive

August 27th, 2012

IABP Randomized Trial Delivers a Shock

holgerthiele131

The lead author of the IABP-SHOCK II trial discusses the practical implications of his study group’s findings.

---

August 27th, 2012

ESC: No Benefit of Intraaortic Balloon Counterpulsation in Cardiogenic Shock

Larry Husten, PHD

Despite a lack of evidence, circulatory support with intraaortic balloon counterpulation (IABP) has a class 1 recommendation in the guidelines and is often used in patients in cardiogenic shock following myocardial infarction for whom early revascularization is planned. That situation may change soon, as no benefit was found for the use of IABP in the […]

---

August 30th, 2011

Intra-Aortic Balloon Counterpulsation (IABP) Burned to a CRISP

Richard A. Lange, MD, MBA and L. David Hillis, MD

Intra-aortic balloon counterpulsation (IABP) is a bust in AMI patients without cardiogenic shock, according to the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction (CRISP AMI) trial. This open-label, 30-center, randomized, controlled trial was performed to determine if a routine strategy of IABP before primary PCI (and continued for at least 12 hours afterward) would […]

---

August 30th, 2011

No Benefit for Routine Counterpulsation Found in CRISP AMI

Larry Husten, PHD

Routine use of intra-aortic balloon counterpulsation (IABC) in STEMI patients who do not have cardiogenic shock does not reduce infarct size, according to a new trial. Results from the CRISP AMI (Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction) trial were presented at the European Society of Cardiology meeting in Paris by Manesh Patel […]

---

August 24th, 2010

Questions About IABP During High-Risk PCI

Larry Husten, PHD

CardioExchange welcomes Simon Redwood and Divaka Perera to discuss their randomized trial of routine intra-aortic balloon pump (IABP) insertion during high-risk PCI for the reduction of major adverse cardiac and cardiovascular events (MACCE) in patients with severe LV dysfunction and extensive coronary disease. Their study, which appears in the Journal of the American Medical Association, […]

---